Title: BILL NO. 574 By: Haste of the Senate
Official Title: BILL NO. 574 By: Haste of the Senate
Number of Sections: 2
Source: versions - Floor (House)
Media Type: application/pdf
Strikethrough Detection: 10 sections found

================================================================================

Section 1:
1 HOUSE OF REPRESENTATIVES - FLOOR VERSION
2 STATE OF OKLAHOMA
3 1st Session of the 60th Legislature (2025)
4 ENGROSSED SENATE
5
and
6
Roe of the House
7
8
9 An Act relating to the Attorney General; amending 74
O.S. 2021, Section 30.5, as last amended by Section
10 3, Chapter 124, O.S.L. 2024 (74 O.S. Supp. 2024,

Section 2:
Section 30.5), which relates to definitions used in
11 the Political Subdivisions Opioid Abatement Grants
Act; modifying definitions; removing obsolete
12 language; amending 74 O.S. 2021, Section 30.6, which
relates to the Oklahoma Opioid Abatement Revolving
13 Fund; authorizing the Office of the Attorney General
to use certain funds for specified purpose; requiring
14 certain approval of projects; updating statutory
reference; amending 74 O.S. 2021, Section 30.8, as
15 amended by Section 2, Chapter 75, O.S.L. 2022 (74
O.S. Supp. 2024, Section 30.8), which relates to
16 disbursement of grants; broadening applicability of
certain provisions; updating statutory language; and
17 providing an effective date.
18
19
20 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
21 SECTION 1. AMENDATORY 74 O.S. 2021, Section 30.5, as
22 last amended by Section 3, Chapter 124, O.S.L. 2024 (74 O.S. Supp.
23 2024, Section 30.5), is amended to read as follows:
24
SB574 HFLR Page 1
BOLD FACE denotes Committee Amendments.
1 Section 30.5. As used in the Political Subdivisions Opioid
2 Abatement Grants Act:
3 1. “Approved purpose” and “approved purposes” mean evidence-
4 based, forward-looking strategies, programming and services used to:
5 a. expand the availability of treatment for individuals
6 affected by opioid use disorders, co-occurring
7 substance use disorders and mental health issues,
8 b. develop, promote and provide evidence-based opioid use
9 prevention strategies,
10 c. provide opioid use disorder and co-occurring substance
11 use disorder avoidance and awareness education,
12 d. decrease the oversupply of licit and illicit opioids,
13 e. support recovery from addiction services performed by
14 qualified and appropriately licensed providers,
15 f. treat opioid use, abuse and disorders including early
16 intervention screening, counseling and support,
17 g. support individuals in treatment and recovery from
18 opioid use, abuse and disorder,
19 h. provide programs or services to connect individuals
20 with opioid use, abuse or disorder, or who are at risk
21 of developing opioid use disorder, co-occurring
22 substance use disorder and mental health issues, with
23 treatment and counseling programs and services,
24
SB574 HFLR Page 2
BOLD FACE denotes Committee Amendments.
1 i. address the needs of individuals who are involved, or
2 who are at risk of becoming involved, in the criminal
3 justice system due to opioid use, abuse or disorder
4 through programs or services in municipal and county
5 criminal judicial systems including prearrest and
6 postarrest diversion programs, pretrial services and
7 drug or recovery courts,
8 j. address the needs of pregnant or parenting women with
9 opioid use, abuse or disorder and their families,
10 k. address the needs of parents and caregivers caring for
11 babies with neonatal abstinence syndrome,
12 l. support efforts to prevent overprescribing and ensure
13 appropriate prescribing and dispensing of opioids,
14 m. support efforts to discourage or prevent misuse of
15 opioids including the oversupply of licit and illicit
16 opioids,
17 n. support efforts to prevent or reduce overdose deaths
18 or other opioid-related harms including through
19 increased availability and distribution of naloxone
20 and other drugs that treat overdoses for use by first
21 responders, persons who have experienced an overdose
22 event, families, schools, community-based service
23 providers, social workers and other members of the
24 public,
SB574 HFLR Page 3
BOLD FACE denotes Committee Amendments.
1 o. reimburse or fund law enforcement and emergency
2 responder expenditures relating to the opioid epidemic
3 including costs of responding to emergency medical or
4 police calls for service, equipment, treatment or
5 response alternatives, mental health response training
6 and training for law enforcement and emergency
7 responders as to appropriate practices and precautions
8 when dealing with opioids or individuals who are at
9 risk of opioid overdose or death,
10 p. reimburse attorney fees and allowable expenses
11 directly related to opioid litigation incurred as part
12 of legal services agreements entered into before May
13 21, 2020,
14 q. support efforts to provide leadership, planning and
15 coordination to abate the opioid epidemic through
16 activities, programs or strategies for prevention and
17 recovery models including regional intergovernmental
18 efforts and not-for-profit agency support,
19 r. support education of youths regarding the dangers of
20 opioid use, abuse and addiction,
21 s. fund training relative to any approved purpose,
22 t. monitor, surveil and evaluate opioid use, abuse or
23 disorder,
24
SB574 HFLR Page 4
BOLD FACE denotes Committee Amendments.
1 u. provide educational and health care services related
2 to nonopioid treatment alternatives, or
3 v. provide opioid abatement as identified by the Oklahoma
4 Opioid Abatement Board as consistent with the purpose
5 of the Political Subdivisions Opioid Abatement Grants
6 Act.
7 Provided that, such strategies, programming and services occurred on
8 or after January 1, 2015.
9 Approved purpose also includes any approved uses as authorized
10 by opioid-related settlement agreements in which the State of
11 Oklahoma is a litigant or participant;
12 2. “Board” means the Oklahoma Opioid Abatement Board;
13 3. “Eligible participant” means any political subdivision
14 impacted by the opioid crisis;
15 4. “Nonapproved purpose” and “nonapproved purposes” mean
16 strategies, programming and services not falling within the
17 definition of approved purpose or approved purposes as defined in
18 this section;
19 5. “Opioid funds” means all monetary amounts obtained through a
20 settlement or judgment by the Attorney General on behalf of this
21 state related to opioid litigation involving pharmaceutical supply
22 chain participants including the Purdue Political Subdivisions
23 Subdivision Fund but excluding all other funds received pursuant to
24 the Purdue Settlement Agreement;
SB574 HFLR Page 5
BOLD FACE denotes Committee Amendments.
1 6. “Opioid grant awards” means grants funded from the Oklahoma
2 Opioid Abatement Revolving Fund, awarded pursuant to the provisions
3 of the Political Subdivisions Opioid Abatement Grants Act;
4 7. “Pharmaceutical supply chain” means the process and channels
5 through which controlled substances are manufactured, marketed,
6 promoted, distributed or dispensed;
7 8. “Pharmaceutical supply chain participant” means any entity
8 that engages in or has engaged in the manufacture, marketing,
9 promotion, distribution or dispensing of an opioid analgesic;
10 9. “Political subdivision” and “political subdivisions” have
11 the same meaning as provided in subparagraphs a, b, c and d of
12 paragraph 11 of Section 152 of Title 51 of the Oklahoma Statutes.
13 Political subdivision also means the board of regents or board of
14 trustees of a state educational institution which is a member of The
15 Oklahoma State System of Higher Education;
16 10. “Purdue Political Subdivision Fund” means the Twelve
17 Million Five Hundred Thousand Dollars ($12,500,000.00) plus any
18 interest accrued thereon received from the Revive Oklahoma Health
19 Foundation consisting of funds received from the Purdue Settlement
20 Agreement designed for distribution to political subdivisions which
21 have executed a release of legal claims as required by the Purdue
22 Settlement Agreement; and
23 11. “Purdue Settlement Agreement” means the settlement
24 agreement entered into by this state and Purdue Pharma L.P., Purdue
SB574 HFLR Page 6
BOLD FACE denotes Committee Amendments.
1 Phar ma, Inc. and the Purdue Frederick Company on March 26, 2019, and
2 approved by the Court on April 2, 2019.
3 SECTION 2. AMENDATORY 74 O.S. 2021, Section 30.6, is
4 amended to read as follows:
5 Section 30.6. A. There is hereby created in the State Treasury
6 a revolving fund for the Office of the Attorney General to be
7 designated the “Oklahoma Opioid Abatement Revolving Fund”. The fund
8 shall be a continuing fund, not subject to fiscal year limitations,
9 and shall consist of all opioid funds obtained through a settlement
10 or judgment by the Attorney General on behalf of the State of
11 Oklahoma related to opioid litigation involving pharmaceutical
12 supply chain participants:
13 1. Designated for deposit in the fund; or
14 2. Appropriated to the fund by the Legislature.
15 B. Provided that the Purdue Political Subdivisions Subdivision
16 Fund shall be maintained in a segregated State Treasury fund within
17 the Oklahoma Opioid Abatement Revolving Fund, and that the Purdue
18 Political Subdivisions Subdivision Fund shall not be commingled with
19 other opioid funds deposited in or appropriated to the Oklahoma
20 Opioid Abatement Revolving Fund.
21 C. The Office of the Attorney General may use not more than ten
22 percent (10%) of the funds appropriated to the Oklahoma Opioid
23 Abatement Revolving Fund for statewide opioid abatement projects
24 that constitute an approved use under the Political Subdivisions
SB574 HFLR Page 7
BOLD FACE denotes Committee Amendments.
1 Opio id Abatement Grants Act. The Oklahoma Opioid Abatement Board
2 shall approve all statewide opioid abatement projects described in
3 this subsection.
4 D. All monies accruing to the credit of the fund are hereby
5 appropriated and may be budgeted and expended by the Attorney
6 General for the purpose of funding opioid grant awards as authorized
7 by this act the Political Subdivisions Opioid Abatement Grants Act.
8 SECTION 3. AMENDATORY 74 O.S. 2021, Section 30.8, as
9 amended by Section 2, Chapter 75, O.S.L. 2022 (74 O.S. Supp. 2024,
10 Section 30.8), is amended to read as follows:
11 Section 30.8. A. 1. The Oklahoma Opioid Abatement Board shall
12 conduct an initial disbursement one or more disbursements of opioid
13 grant awards to participating eligible participants. Such opioid
14 grant awards shall be allocated amongst the different participating
15 eligible participants based on the following criteria:
16 a. the number of people per capita suffering from opioid
17 use disorder in the participating political
18 subdivision, or in the absence of such information,
19 the opioid prescription rate in the political
20 subdivision compared to the national average opioid
21 prescription rate,
22 b. the number of opioid overdose deaths in the
23 participating political subdivision,
24
SB574 HFLR Page 8
BOLD FACE denotes Committee Amendments.
1 c. the amount of opioids distributed within the
2 participating political subdivision, and
3 d. the amount of attorney fees and allowable expenses
4 associated with legal services agreements directly
5 related to opioid litigation incurred as part of legal
6 services agreements entered into before May 21, 2020,
7 or
8 e. any other criteria established by the Board.
9 2. Grant awards shall be subject to legal services agreements
10 entered into by eligible participants.
11 3. Initial opioid Opioid grant awards as provided for in this
12 subsection shall be listed in an opioid grant award distribution
13 table reviewed and approved by the Board to ensure that such awards
14 adhere to the criteria adopted by the Board.
15 B. Following the awarding of opioid grant awards pursuant to
16 subsection A of this section, any remaining unencumbered balance in
17 Funds accrued in the Oklahoma Opioid Abatement Revolving Fund shall
18 be available to the Board to award as grants to eligible
19 participants; provided such awards shall only be utilized by
20 eligible participants for approved purposes.
21 C. In the event an eligible participant merges, dissolves or
22 ceases to exist, any remaining allocations of an awarded opioid
23 grant award in excess of Five Hundred Dollars ($500.00) shall be
24
SB574 HFLR Page 9
BOLD FACE denotes Committee Amendments.
1 real located equitably based on the composition of the successor
2 eligible participant or the successor eligible participants.
3 SECTION 4. This act shall become effective November 1, 2025.
4
5 COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES, dated
04/16/2025 – DO PASS.
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SB574 HFLR Page 10
BOLD FACE denotes Committee Amendments.
[DELETED:  P B H  a R]
[DELETED:  P e d p d s t s p]
[DELETED:  P a a a s s s]
[DELETED:  P r r s s f m]
[DELETED:  P p p]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P t t]
[DELETED:  P t t a]
[DELETED:  P]


================================================================================

Raw Text:
1 HOUSE OF REPRESENTATIVES - FLOOR VERSION
2 STATE OF OKLAHOMA
3 1st Session of the 60th Legislature (2025)
4 ENGROSSED SENATE
BILL NO. 574 By: Haste of the Senate
5
and
6
Roe of the House
7
8
9 An Act relating to the Attorney General; amending 74
O.S. 2021, Section 30.5, as last amended by Section
10 3, Chapter 124, O.S.L. 2024 (74 O.S. Supp. 2024,
Section 30.5), which relates to definitions used in
11 the Political Subdivisions Opioid Abatement Grants
Act; modifying definitions; removing obsolete
12 language; amending 74 O.S. 2021, Section 30.6, which
relates to the Oklahoma Opioid Abatement Revolving
13 Fund; authorizing the Office of the Attorney General
to use certain funds for specified purpose; requiring
14 certain approval of projects; updating statutory
reference; amending 74 O.S. 2021, Section 30.8, as
15 amended by Section 2, Chapter 75, O.S.L. 2022 (74
O.S. Supp. 2024, Section 30.8), which relates to
16 disbursement of grants; broadening applicability of
certain provisions; updating statutory language; and
17 providing an effective date.
18
19
20 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
21 SECTION 1. AMENDATORY 74 O.S. 2021, Section 30.5, as
22 last amended by Section 3, Chapter 124, O.S.L. 2024 (74 O.S. Supp.
23 2024, Section 30.5), is amended to read as follows:
24
SB574 HFLR Page 1
BOLD FACE denotes Committee Amendments.

1 Section 30.5. As used in the Political Subdivisions Opioid
2 Abatement Grants Act:
3 1. “Approved purpose” and “approved purposes” mean evidence-
4 based, forward-looking strategies, programming and services used to:
5 a. expand the availability of treatment for individuals
6 affected by opioid use disorders, co-occurring
7 substance use disorders and mental health issues,
8 b. develop, promote and provide evidence-based opioid use
9 prevention strategies,
10 c. provide opioid use disorder and co-occurring substance
11 use disorder avoidance and awareness education,
12 d. decrease the oversupply of licit and illicit opioids,
13 e. support recovery from addiction services performed by
14 qualified and appropriately licensed providers,
15 f. treat opioid use, abuse and disorders including early
16 intervention screening, counseling and support,
17 g. support individuals in treatment and recovery from
18 opioid use, abuse and disorder,
19 h. provide programs or services to connect individuals
20 with opioid use, abuse or disorder, or who are at risk
21 of developing opioid use disorder, co-occurring
22 substance use disorder and mental health issues, with
23 treatment and counseling programs and services,
24
SB574 HFLR Page 2
BOLD FACE denotes Committee Amendments.

1 i. address the needs of individuals who are involved, or
2 who are at risk of becoming involved, in the criminal
3 justice system due to opioid use, abuse or disorder
4 through programs or services in municipal and county
5 criminal judicial systems including prearrest and
6 postarrest diversion programs, pretrial services and
7 drug or recovery courts,
8 j. address the needs of pregnant or parenting women with
9 opioid use, abuse or disorder and their families,
10 k. address the needs of parents and caregivers caring for
11 babies with neonatal abstinence syndrome,
12 l. support efforts to prevent overprescribing and ensure
13 appropriate prescribing and dispensing of opioids,
14 m. support efforts to discourage or prevent misuse of
15 opioids including the oversupply of licit and illicit
16 opioids,
17 n. support efforts to prevent or reduce overdose deaths
18 or other opioid-related harms including through
19 increased availability and distribution of naloxone
20 and other drugs that treat overdoses for use by first
21 responders, persons who have experienced an overdose
22 event, families, schools, community-based service
23 providers, social workers and other members of the
24 public,
SB574 HFLR Page 3
BOLD FACE denotes Committee Amendments.

1 o. reimburse or fund law enforcement and emergency
2 responder expenditures relating to the opioid epidemic
3 including costs of responding to emergency medical or
4 police calls for service, equipment, treatment or
5 response alternatives, mental health response training
6 and training for law enforcement and emergency
7 responders as to appropriate practices and precautions
8 when dealing with opioids or individuals who are at
9 risk of opioid overdose or death,
10 p. reimburse attorney fees and allowable expenses
11 directly related to opioid litigation incurred as part
12 of legal services agreements entered into before May
13 21, 2020,
14 q. support efforts to provide leadership, planning and
15 coordination to abate the opioid epidemic through
16 activities, programs or strategies for prevention and
17 recovery models including regional intergovernmental
18 efforts and not-for-profit agency support,
19 r. support education of youths regarding the dangers of
20 opioid use, abuse and addiction,
21 s. fund training relative to any approved purpose,
22 t. monitor, surveil and evaluate opioid use, abuse or
23 disorder,
24
SB574 HFLR Page 4
BOLD FACE denotes Committee Amendments.

1 u. provide educational and health care services related
2 to nonopioid treatment alternatives, or
3 v. provide opioid abatement as identified by the Oklahoma
4 Opioid Abatement Board as consistent with the purpose
5 of the Political Subdivisions Opioid Abatement Grants
6 Act.
7 Provided that, such strategies, programming and services occurred on
8 or after January 1, 2015.
9 Approved purpose also includes any approved uses as authorized
10 by opioid-related settlement agreements in which the State of
11 Oklahoma is a litigant or participant;
12 2. “Board” means the Oklahoma Opioid Abatement Board;
13 3. “Eligible participant” means any political subdivision
14 impacted by the opioid crisis;
15 4. “Nonapproved purpose” and “nonapproved purposes” mean
16 strategies, programming and services not falling within the
17 definition of approved purpose or approved purposes as defined in
18 this section;
19 5. “Opioid funds” means all monetary amounts obtained through a
20 settlement or judgment by the Attorney General on behalf of this
21 state related to opioid litigation involving pharmaceutical supply
22 chain participants including the Purdue Political Subdivisions
23 Subdivision Fund but excluding all other funds received pursuant to
24 the Purdue Settlement Agreement;
SB574 HFLR Page 5
BOLD FACE denotes Committee Amendments.

1 6. “Opioid grant awards” means grants funded from the Oklahoma
2 Opioid Abatement Revolving Fund, awarded pursuant to the provisions
3 of the Political Subdivisions Opioid Abatement Grants Act;
4 7. “Pharmaceutical supply chain” means the process and channels
5 through which controlled substances are manufactured, marketed,
6 promoted, distributed or dispensed;
7 8. “Pharmaceutical supply chain participant” means any entity
8 that engages in or has engaged in the manufacture, marketing,
9 promotion, distribution or dispensing of an opioid analgesic;
10 9. “Political subdivision” and “political subdivisions” have
11 the same meaning as provided in subparagraphs a, b, c and d of
12 paragraph 11 of Section 152 of Title 51 of the Oklahoma Statutes.
13 Political subdivision also means the board of regents or board of
14 trustees of a state educational institution which is a member of The
15 Oklahoma State System of Higher Education;
16 10. “Purdue Political Subdivision Fund” means the Twelve
17 Million Five Hundred Thousand Dollars ($12,500,000.00) plus any
18 interest accrued thereon received from the Revive Oklahoma Health
19 Foundation consisting of funds received from the Purdue Settlement
20 Agreement designed for distribution to political subdivisions which
21 have executed a release of legal claims as required by the Purdue
22 Settlement Agreement; and
23 11. “Purdue Settlement Agreement” means the settlement
24 agreement entered into by this state and Purdue Pharma L.P., Purdue
SB574 HFLR Page 6
BOLD FACE denotes Committee Amendments.

1 Phar ma, Inc. and the Purdue Frederick Company on March 26, 2019, and
2 approved by the Court on April 2, 2019.
3 SECTION 2. AMENDATORY 74 O.S. 2021, Section 30.6, is
4 amended to read as follows:
5 Section 30.6. A. There is hereby created in the State Treasury
6 a revolving fund for the Office of the Attorney General to be
7 designated the “Oklahoma Opioid Abatement Revolving Fund”. The fund
8 shall be a continuing fund, not subject to fiscal year limitations,
9 and shall consist of all opioid funds obtained through a settlement
10 or judgment by the Attorney General on behalf of the State of
11 Oklahoma related to opioid litigation involving pharmaceutical
12 supply chain participants:
13 1. Designated for deposit in the fund; or
14 2. Appropriated to the fund by the Legislature.
15 B. Provided that the Purdue Political Subdivisions Subdivision
16 Fund shall be maintained in a segregated State Treasury fund within
17 the Oklahoma Opioid Abatement Revolving Fund, and that the Purdue
18 Political Subdivisions Subdivision Fund shall not be commingled with
19 other opioid funds deposited in or appropriated to the Oklahoma
20 Opioid Abatement Revolving Fund.
21 C. The Office of the Attorney General may use not more than ten
22 percent (10%) of the funds appropriated to the Oklahoma Opioid
23 Abatement Revolving Fund for statewide opioid abatement projects
24 that constitute an approved use under the Political Subdivisions
SB574 HFLR Page 7
BOLD FACE denotes Committee Amendments.

1 Opio id Abatement Grants Act. The Oklahoma Opioid Abatement Board
2 shall approve all statewide opioid abatement projects described in
3 this subsection.
4 D. All monies accruing to the credit of the fund are hereby
5 appropriated and may be budgeted and expended by the Attorney
6 General for the purpose of funding opioid grant awards as authorized
7 by this act the Political Subdivisions Opioid Abatement Grants Act.
8 SECTION 3. AMENDATORY 74 O.S. 2021, Section 30.8, as
9 amended by Section 2, Chapter 75, O.S.L. 2022 (74 O.S. Supp. 2024,
10 Section 30.8), is amended to read as follows:
11 Section 30.8. A. 1. The Oklahoma Opioid Abatement Board shall
12 conduct an initial disbursement one or more disbursements of opioid
13 grant awards to participating eligible participants. Such opioid
14 grant awards shall be allocated amongst the different participating
15 eligible participants based on the following criteria:
16 a. the number of people per capita suffering from opioid
17 use disorder in the participating political
18 subdivision, or in the absence of such information,
19 the opioid prescription rate in the political
20 subdivision compared to the national average opioid
21 prescription rate,
22 b. the number of opioid overdose deaths in the
23 participating political subdivision,
24
SB574 HFLR Page 8
BOLD FACE denotes Committee Amendments.

1 c. the amount of opioids distributed within the
2 participating political subdivision, and
3 d. the amount of attorney fees and allowable expenses
4 associated with legal services agreements directly
5 related to opioid litigation incurred as part of legal
6 services agreements entered into before May 21, 2020,
7 or
8 e. any other criteria established by the Board.
9 2. Grant awards shall be subject to legal services agreements
10 entered into by eligible participants.
11 3. Initial opioid Opioid grant awards as provided for in this
12 subsection shall be listed in an opioid grant award distribution
13 table reviewed and approved by the Board to ensure that such awards
14 adhere to the criteria adopted by the Board.
15 B. Following the awarding of opioid grant awards pursuant to
16 subsection A of this section, any remaining unencumbered balance in
17 Funds accrued in the Oklahoma Opioid Abatement Revolving Fund shall
18 be available to the Board to award as grants to eligible
19 participants; provided such awards shall only be utilized by
20 eligible participants for approved purposes.
21 C. In the event an eligible participant merges, dissolves or
22 ceases to exist, any remaining allocations of an awarded opioid
23 grant award in excess of Five Hundred Dollars ($500.00) shall be
24
SB574 HFLR Page 9
BOLD FACE denotes Committee Amendments.

1 real located equitably based on the composition of the successor
2 eligible participant or the successor eligible participants.
3 SECTION 4. This act shall become effective November 1, 2025.
4
5 COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES, dated
04/16/2025 – DO PASS.
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SB574 HFLR Page 10
BOLD FACE denotes Committee Amendments.

[DELETED:  P B H  a R]
[DELETED:  P e d p d s t s p]
[DELETED:  P a a a s s s]
[DELETED:  P r r s s f m]
[DELETED:  P p p]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P t t]
[DELETED:  P t t a]
[DELETED:  P]